Neffy, a single-dose nasal spray administered into one nostril, is approved for use in adult and pediatric patients who weigh at least 30 kilograms.
"Some people, particularly children, may delay or avoid treatment due to fear of injections," said Kelly Stone, an associate director at the FDA's Center for Drug Evaluation and Research, adding that the availability of the nasal spray may reduce barriers to rapid treatment.
this post was submitted on 11 Aug 2024
46 points (97.9% liked)
Tech
417 readers
2 users here now
A community for high quality news and discussion around technological advancements and changes
Things that fit:
- New tech releases
- Major tech changes
- Major milestones for tech
- Major tech news such as data breaches, discontinuation
Things that don't fit
- Minor app updates
- Government legislation
- Company news
- Opinion pieces
founded 7 months ago
MODERATORS